Raloxifene Hydrochloride
NDC 50268-694, Raloxifene Hydrochloride, tablet, film coated, from AvPAK.
- Product NDC
- 50268-694
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208206
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-694 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RALOXIFENE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-694-15 | 50268069415 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-694-15) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-694-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f7eb934-aa60-51e1-e053-2a91aa0a3914NADAC price for package 50268069415
GET /v1/drugs/nadac/50268069415
Use it
Look up 50268-694 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-694 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-694. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.